Evidence map›Paper›PMID 34549633›Full record

ArticleJournal of diabetes science and technology2022

Evaluation of a New Neural Network Classifier for Diabetic Retinopathy.

Or Katz, Dan Presil, Liz Cohen, Roi Nachmani, Naomi Kirshner, Yaacov Hoch, Tsvi Lev, Aviel Hadad, Richard John Hewitt, David R Owens

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Or KatzNEC Israeli Research Center, Herzeliya, Israel.
Dan PresilNEC Israeli Research Center, Herzeliya, Israel.ORCID 0000-0003-0917-1319
Liz CohenNEC Israeli Research Center, Herzeliya, Israel.
Roi NachmaniNEC Israeli Research Center, Herzeliya, Israel.
Naomi KirshnerNEC Israeli Research Center, Herzeliya, Israel.
Yaacov HochNEC Israeli Research Center, Herzeliya, Israel.
Tsvi LevNEC Israeli Research Center, Herzeliya, Israel.
Aviel HadadMD MPH, Ophthalmology Department, Soroka University Medical Center, Be'er Sheva, South District, Israel.
Richard John HewittUniversity of Exeter, Exeter, Devon, UK.
David R OwensProfessor of Diabetes, Swansea University Medical School, Swansea, Wales, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedical image segmentation is a well-studied subject within the field of image processing. The goal of this research is to create an AI retinal screening grading system that is both accurate and fast. We introduce a new segmentation network which achieves state-of-the-art results on semantic segmentation of color fundus photographs. By applying the net-work to identify anatomical markers of diabetic retinopathy (DR) and diabetic macular edema (DME), we collect sufficient information to classify patients by grades R0 and R1 or above, M0 and M1.

methodsThe AI grading system was trained on screening data to evaluate the presence of DR and DME. The core algorithm of the system is a deep learning network that segments relevant anatomical features in a retinal image. Patients were graded according to the standard NHS Diabetic Eye Screening Program feature-based grading protocol.

resultsThe algorithm performance was evaluated with a series of 6,981 patient retinal images from routine diabetic eye screenings. It correctly predicted 98.9% of retinopathy events and 95.5% of maculopathy events. Non-disease events prediction rate was 68.6% for retinopathy and 81.2% for maculopathy.

conclusionThis novel deep learning model was trained and tested on patient data from annual diabetic retinopathy screenings can classify with high accuracy the DR and DME status of a person with diabetes. The system can be easily reconfigured according to any grading protocol, without running a long AI training procedure. The incorporation of the AI grading system can increase the graders' productivity and improve the final outcome accuracy of the screening process.

Indexed as

Diabetes MellitusDiabetic RetinopathyMacular EdemaDiagnostic Techniques, OphthalmologicalHumansNeural Networks, ComputerPhotographyAIdiabetic retinopathyimagingscreening

Identifiers

PMID34549633
PMCPMC9631541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.